India to Tajikistan Pharmaceutical Export (2026) — $45.9M, 178 Suppliers | TransData Nexus

India to Tajikistan Pharmaceutical Export (2026) — $45.9M, 178 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Tajikistan

#	Formulation	Value	Share
1	Nutrikoff Lozenges N 3x6 (pineapple Flav	$1.5M	3.2%
2	Nutrikoff Lozenges N 3x6 (mint Flavour)	$1.5M	3.2%
3	Nutrikoff Lozenges N 3x6 (orange Flavour	$1.4M	3.1%
4	Nutrikoff Lozenges N 3x6 (honey Lemon Fl	$1.4M	3.1%
5	Amoxycillin Capsules 500mg (each Har	$1.1M	2.4%
6	Dtp-hepb-hib (pentavalent Vaccine) Dtp-hepb-hib (pentavalent Vaccine) Fully Liq…	$783.7K	1.7%
7	Mgl IV Bottle 100 ML Taz Exp	$668.4K	1.5%
8	Mixed Vaccine for Mmr-viral Vaccine- (inv)	$632.7K	1.4%
9	Amoxycillin Capsules 250mg (each Hard	$468.0K	1.0%
10	Harmless Medicine/pharmaceuticals Goods	$223.0K	0.5%
11	Acipran(1 Box	$210.1K	0.5%
12	Harmlessmedicine,ampicillinsulbactam1,5gr	$181.8K	0.4%
13	Harmlessmedicine - Ampi-f - Ampicillinsulbactam1,5gr	$157.2K	0.3%
14	Easy Five Tt Vaccine Dtwp-hepb-hib Pentavalent Vaccine with Vaccine Vial Monito…	$154.1K	0.3%
15	Pharmaceutical Products-acipran (1 Box =10 Alu Alu Blister X 10 Tablets)generic…	$123.1K	0.3%

India exports 19+ pharmaceutical formulations to Tajikistan with a combined trade value of $45.9M. Key products include Vaccine ($633K), Ampicillin ($120K), Rifampicin ($102K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 7,157 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Tajikistan Trade Routes

1Vaccine$633K

2Ampicillin$120K

3Rifampicin$102K

These are the top pharmaceutical products exported from India to Tajikistan, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Tajikistan buyers, regulatory requirements, and logistics for that specific product corridor. Products include Vaccine ($633K), Ampicillin ($120K), Rifampicin ($102K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Tajikistan

1Evolet Healthcare Private Limited

$12.0M

2Biomedicare India Private Limited

$6.2M

3Yesha Pharmaceutical

$1.8M

4Avantika Medex Private Limited

$1.6M

5Brawn Laboratories Limited

Port Analysis — India to Tajikistan Pharmaceutical Shipments

Indian Export Ports

NHAVA SHEVA SEA (INNSA1)16.7%

AHEMDABAD ICD1.0%

PIYALA ICD (INBFR6)4.8%

TUGLAKABAD ICD6.8%

MUNDRA SEA (INMUN1)3.6%

Tajikistan Import Ports

Dushanbe34.8%

DUSHANBE44.2%

Khudzhand1.8%

Bandar Abbas2.7%

BANDAR ABBAS3.4%

Trade Statistics

Total Value$45.9M

Shipments7,157

Indian Exporters178

Tajikistan Buyers284

Avg Shipment$6K

Products5,382

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Tajikistan Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and Tajikistan has experienced significant growth over the past decade. In 2024, India's pharmaceutical exports to Tajikistan were valued at $33.77 million, marking a substantial increase from previous years. This upward trajectory reflects the strengthening economic ties and the growing demand for quality pharmaceutical products in Tajikistan.

A pivotal milestone in this bilateral trade occurred in July 2024, when representatives from over 70 Indian pharmaceutical companies met with Tajik entrepreneurs in Dushanbe. This meeting underscored Tajikistan's commitment to expanding trade and investment cooperation with India, particularly in the pharmaceutical sector. The discussions focused on establishing joint ventures for pharmaceutical production, aligning with Tajikistan's strategic objective of industrial development during the 2022-2026 period. (tajmedun.tj)

2India's Market Position

India holds a dominant position in Tajikistan's pharmaceutical import market. In 2023, Tajikistan's pharmaceutical imports from India were valued at $28.15 million, accounting for a significant portion of the country's total pharmaceutical imports. This substantial share highlights India's strategic importance as a supplier of high-quality pharmaceutical formulations to Tajikistan.

Recent Developments

Tajikistan Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Tajikistan must adhere to the guidelines set by the National Drug Regulatory Authority, which operates under WHO-GMP standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) format, which includes detailed information on the product's quality, safety, and efficacy. Bioequivalence studies are mandatory for generic products to demonstrate therapeutic equivalence to the reference listed drug. The registration timeline can vary, but companies should anticipate a process that may take several months, depending on the complexity of the product and the completeness of the submitted documentation.

2GMP & Facility Requirements

Tajikistan requires that manufacturing facilities comply with Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization. Indian manufacturers must undergo inspections by Tajik authorities to verify compliance with these standards. The inspection process includes a thorough evaluation of the facility's quality management systems, production processes, and documentation practices. Tajikistan has established mutual recognition agreements with several countries, facilitating the acceptance of GMP certifications from recognized authorities. However, Indian manufacturers should confirm the specific requirements and recognition status to ensure a smooth registration process.

3Import Documentation

Importing pharmaceutical products into Tajikistan necessitates obtaining an import license from the Ministry of Healthcare. The application for this license must include a copy of the license for pharmaceutical activity, documents confirming the conditions for storage, wholesale distribution, or manufacturing of drugs and medical goods, and other relevant certificates. Additionally, a Certificate of Pharmaceutical Product (CPP) and a Certificate of Analysis (CoA) are required to verify the product's quality and compliance with Tajikistan's standards. Customs procedures involve the submission of these documents for clearance, and adherence to Tajikistan's import regulations is essential to avoid delays or rejections.

EXPORT_TRENDS

TransData Nexus Research · Tajikistan regulatory databasesMar 2026

FAQ — India to Tajikistan Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Tajikistan?

India exported pharmaceuticals worth $45.9M to Tajikistan across 7,157 verified shipments.

Who are the top Indian pharmaceutical exporters to Tajikistan?

1. EVOLET HEALTHCARE PRIVATE LIMITED — $12.0M. 2. BIOMEDICARE INDIA PRIVATE LIMITED — $6.2M. 3. YESHA PHARMACEUTICAL — $1.8M. Total: 178 suppliers.

Which companies in Tajikistan import pharmaceuticals from India?

1. AVRUPO PHARMA — $5.9M. 2. ASIAPHARM LLC — $4.5M. 3. ASIAPHARM LLC. — $4.3M. 284 buyers total.

What pharmaceutical products does India export most to Tajikistan?

1. Nutrikoff Lozenges N 3x6 (pineapple Flav ($1.5M, 3.2%); 2. Nutrikoff Lozenges N 3x6 (mint Flavour) ($1.5M, 3.2%); 3. Nutrikoff Lozenges N 3x6 (orange Flavour ($1.4M, 3.1%); 4. Nutrikoff Lozenges N 3x6 (honey Lemon Fl ($1.4M, 3.1%); 5. Amoxycillin Capsules 500mg (each Har ($1.1M, 2.4%)

Which ports handle pharmaceutical shipments from India to Tajikistan?

Export: NHAVA SHEVA SEA (INNSA1), AHEMDABAD ICD, PIYALA ICD (INBFR6), TUGLAKABAD ICD, MUNDRA SEA (INMUN1). Import: Dushanbe, DUSHANBE, Khudzhand, Bandar Abbas, BANDAR ABBAS.

Why does Tajikistan import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $45.9M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Tajikistan?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Tajikistan pharmaceutical trade?

$6.4K per consignment across 7,157 shipments.

How many Indian pharmaceutical companies export to Tajikistan?

178 Indian companies. Largest: EVOLET HEALTHCARE PRIVATE LIMITED with $12.0M.

How can I find verified Indian pharmaceutical suppliers for Tajikistan?

TransData Nexus covers 178 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Tajikistan identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 7,157 verified shipments from 178 Indian exporters to 284 Tajikistan buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

178 Exporters

284 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Tajikistan Pharmaceutical Export

Top Pharmaceutical Formulations — India to Tajikistan

Top Pharmaceutical Products — India to Tajikistan Trade Routes

Top Indian Exporters to Tajikistan

Port Analysis — India to Tajikistan Pharmaceutical Shipments

Indian Export Ports

Tajikistan Import Ports

Trade Statistics

Other Destinations

India–Tajikistan Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Recent Developments

Top Tajikistan Buyers from India

Product Routes

Full Dataset Access

Tajikistan Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Tajikistan

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Tajikistan

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Tajikistan Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Tajikistan for Indian Pharma

1Market Size & Growth